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Cells, tissues, and biological fluids contain a diverse repertoire of many tens of thousands of structurally
distinct lipids that play multiple roles in cellular signaling, bioenergetics, and membrane structure and func-
tion. In an era where lipid-related disease states predominate, lipidomics has assumed a prominent role in
systems biology through its unique ability to directly identify functional alterations in multiple lipid metabolic
and signaling networks. The development of shotgun lipidomics has led to the facile accrual of high density
information on alterations in the lipidome mediating physiologic cellular adaptation during health and path-
ologic alterations during disease. Through both targeted and nontargeted investigations, lipidomics has
already revealed the chemical mechanisms underlying many lipid-related disease states.The Multiple Roles of Lipids
in Cellular Function
Lipids play multiple diverse roles in
cellular function that must be effectively
integrated into chemical and genetic
networks to allow each cell to fulfill its
specific biological function. By some
recent estimates, cellular lipids encom-
pass tens of thousands of structurally
distinct compounds (van Meer, 2005;
Shevchenko and Simons, 2010). On the
most fundamental level, lipids are the
main components of biological mem-
branes where they serve to sequester,
organize, and distribute the molecular
entities necessary for life processes. On
a second level, lipids (e.g., fatty acids
and triglycerides) are important fuel sour-
ces for many cell types. Lipids supply
energy for cellular function through oxida-
tion and facilitate metabolic flexibility
through their ability to store chemical
energy during times of caloric excess
and harvest the energy stored in lipids
(e.g., triglycerides) during energy deple-
tion. Moreover, lipids play prominent roles
in the regulation of cellular bioenergetics
through integrating oxidative metabolic
programs (Michalik et al., 2006), modu-
lating systemic energy balance through
eicosanoid and lysolipid production
(Vegiopoulos et al., 2010; Skoura and
Hla, 2009), and regulating mitochondrial
electron transport chain flux and coupling
efficiency (e.g., cardiolipin, fatty acids)284 Chemistry & Biology 18, March 25, 2011(Zhang et al., 2002; Breen et al., 2005).
On a third level, lipid membranes serve
as molecular scaffolds that promote pro-
ductive interactions among membrane-
associated moieties that regulate cellular
signaling to facilitate the transmission of
biological information across cell mem-
branes, between intracellular compart-
ments or to other cells. Furthermore, the
molecular dynamics and physical proper-
ties of membrane bilayers are critical
determinants of the activities of trans-
membrane proteins such as ion channels
and ion pumps (e.g., Schmidt and
MacKinnon, 2008). Through the use of a
diverse structural repertoire of lipids to
regulate membrane surface charge,
curvature and molecular dynamics, many
biological functions of membranes can
be fulfilled. Thus, the precise covalent
nature of membrane molecular constitu-
ents within the lipid bilayers, including
alterations in class, subclass and indi-
vidual molecular species are important
determinants of membrane structure that
facilitate many specialized membrane-
mediated cellular functions (Figure 1).
Finally, many classes of lipids serve as
second messengers of signal transduc-
tion (e.g., eicosanoids, lysolipids, phos-
phoinositides, endocannabinoids) that
reside in biologic membranes in a latent
state which can be activated either by
hydrolysis and/or covalent transformation
(e.g., Wolf and Gross, 1985; Shaw andª2011 Elsevier Ltd All rights reservedCantley, 2006; Chiang et al., 2006; Simon
and Cravatt, 2006). During evolution,
adaptive alterations in membrane struc-
ture and function were selected by
their integrated effects on cellular metab-
olism and signaling. This evolutionary
process has led to the development of
multiple membrane-delimited compart-
ments (e.g., mitochondria, peroxisomes,
endoplasmic reticulum, etc.) which
perform integrated specialized processes
that are essential for efficient cellular func-
tion and adaptation to external perturba-
tions (Figure 1).
The Growth of Lipidomics
in Systems Biology
Similar to the Systems Biology fields of
genomics and proteomics, the field of
lipidomics begins with the identification
and quantitation of lipids that collectively
comprise the lipidome (i.e., the collection
of lipid molecular species) in each
cell, tissue, or biologic fluid of interest.
Through identification and quantitation of
alterations in lipid molecular species,
a high-density matrix containing funda-
mental information on themetabolic state,
nutritional history and functional status of
each cell type can be obtained. Moreover,
the field of lipidomics encompasses the
roles of specific membrane lipid constitu-
ents in mediating membrane domain
formation (e.g., rafts), in facilitating
interactions among spatially interwoven
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Figure 1. The Pleiotropic Roles of Lipids in Cellular Function
Lipids fulfill multiple roles in cellular function including cellular signaling (top left) through: (1) harboring latent second messengers of signal transduction that are
released by phospholipases (PLA, PLC, and PLD enzymes); (2) covalent transformation of membrane lipids into biologically active ligands by kinases (e.g., PI
3,4,5 triphosphate); (3) providing molecular scaffolds for the assembly of protein complexes mediating receptor/effector coupling (e.g., G protein-coupled recep-
tors); and (4) coupling the vibrational, rotational, and translational energies and dynamics of membrane lipids to transmembrane proteins such as ion channels
and transporters (top right) thereby facilitating dynamic cooperative lipid-protein interactions that collectively regulate transmembrane protein function. More-
over, lipids play essential roles in mitochondrial cellular bioenergetics (bottom) through the use of fatty acids as substrates for mitochondrial b-oxidation (bottom
left) that result in the production of reducing equivalents (e.g., NADH). The chemical energy in NADH is harvested through oxidative phosphorylation whose flux is
tightly regulated by mitochondrial membrane constituents including cardiolipins which modulate electron transport chain (ETC) supercomplex formation.
A second mechanism modulating mitochondrial energy production is the dissipation of the proton gradient by the transmembrane flip-flop of fatty acids in
the mitochondrial inner membrane bilayer as well as the fatty acid-mediated regulation of uncoupling proteins (UCP).
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protein receptor-effector coupling), and
in providing dynamic highly specialized
molecular scaffolds for the construction
of microscopic and macroscopic chemi-
cal assemblies necessary for life pro-
cesses (e.g., Klose et al., 2010).
The large majority of diseases in indus-
trialized societies in the 21st century,
such as diabetes, obesity, atheroscle-
rosis, myocardial infarction, and stroke,
to name a few, are lipid-related disorders
(e.g., Unger, 2002; Unger et al., 2010;
Dixon, 2010). Thus, lipidomics offers a
direct and unique perspective into the
pathologic alterations in cellular regula-
tory networks that promote lipid-mediateddisease states. Lipidomics has now
matured into a field that has already iden-
tified biomarkers predictive of disease
states, alterations in the profiles of lipids
that reflect disease severity and can be
used to determine treatment efficacy
(Nomura et al., 2010; Porter et al., 2010;
Bartz et al., 2007). Thus, through the
comprehensive analysis of alterations in
lipid molecular species and their abun-
dance, the field of lipidomics produces
a high-density array of diagnostic, thera-
peutic and mechanistic information which
has greatly impacted our understanding
of the complex roles of lipids in health
and disease (e.g., Nomura et al., 2010;
Mancuso et al., 2009; Liu et al., 2010).Chemistry & Biology 18, March 25, 2011The Challenges of Early Lipid
Analytical Techniques
Historically, progress in lipid research has
been hindered by the difficulties inherent
in the identification of lipid structure
(e.g., the chemical nature and regiospeci-
ficity of aliphatic chains in each lipid
class and subclass) and quantitation of
individual molecular species. Over many
decades multiple approaches have
been applied to the separation, quantita-
tion and characterization of lipids in-
cluding thin layer chromatography, gas
chromatography, NMR, and HPLC in con-
junction with a variety of complementary
procedures including chemical hydro-
lysis, regiospecific enzymatic cleavageª2011 Elsevier Ltd All rights reserved 285
Chemistry & Biology
Crosstalkand spectrophotometric assays in at-
tempts to determine the diversity of lipid
structures in biological systemsandquan-
titate their abundance. However, these
strategies required multiple sequential
steps each of which possessed limited
sensitivity and accuracy that collectively
resulted in the propagation of errors.
Although the utility of GC-MS for the
analysis of volatile nonpolar lipids has
provided a robust platform for analysis
of volatile lipids for many years, the over-
whelming majority of cellular membrane
constituents are nonvolatile charged
moieties that are not accessible by GC-
MSmethods. Thus, progress in lipidomics
was largely dependent on the develop-
ment of a mass spectrometric approach
for the identification and quantitation of
charged nonvolatile lipids.
The Emergence of Sequential HPLC
and Mass Spectrometry as
a Principal Strategy for Lipidomic
Analyses
The development of fast atom bombard-
ment-mass spectrometry (FAB-MS) in
the early 1980s allowed the relatively
soft ionization and desorption of intact
nonvolatile charged lipids from a variety
of chemical matrices resulting in the
identification of the m/z of the molecular
ion. Using HPLC separations (either
straight phase, reversed phase, or multi-
dimensional orthogonal separations [e.g.,
sequential SCX and RPHPLC]) followed
by FAB-MS, the molecular ions corre-
sponding to individual lipid molecular
species in mammalian tissues could be
identified (Gross, 1984). Thus, in conjunc-
tion with regiospecific enzymatic hydro-
lysis, the identification and quantitation
of nonvolatile lipid molecular species
was possible. This approach demon-
strated that canine myocardial sarco-
lemmal membranes are composed
predominantly of plasmalogen molecular
constituents, that themajor storage depot
for arachidonic acid in myocardium was
plasmalogen molecular species and that
specialized intracellular membrane com-
partments were composed of discrete
sets of phospholipid classes, subclasses,
and individual molecular species (Gross,
1984, 1985). Utilization of HPLC followed
by FAB-MS provided abundant informa-
tion on the specialized lipid compositions
present in diverse cell types, subcellular
compartments, and many organ systems286 Chemistry & Biology 18, March 25, 2011including the human heart (Hazen et al.,
1993). The use of HPLC followed by direct
ionization of intact nonvolatile lipids and
analysis by mass spectrometry heralded
the beginning of a new era in under-
standing the pleiotropic roles of lipids in
cellular function.
Electrospray Ionization as an
Enabling Technology for Deep
Penetrance into the Lipidome
Over the last decade, several different
strategies for analysis of cellular lipi-
domes have been developed. Here, we
will first focus on electrospray ionization-
mass spectrometry (ESI-MS) and its
robust contribution to the development
of the field and subsequently discuss
other emerging methodologies later in
the text. Currently, the most commonly
employed ionization method for lipido-
mics is ESI-MS which was developed by
the late John Fenn (Fenn et al., 1989) in
his Nobel Prize winning work. Electro-
spray ionization is effected by passage
of a solution containing analytes
through a narrow orifice at a high electric
potential (typically 4 kV) resulting in the
formation of charged droplets in the ioni-
zation chamber. The use of ESI improved
ionization efficiencies for nonvolatile
charged lipids by two to three orders of
magnitude in comparison to FAB-MS
methods (Han and Gross, 1994). The ioni-
zation efficiency of most lipids during the
electrospray process is largely dependent
on the charge density present in each
lipid. Thus, the charge state and magni-
tude of the dipole in the lipid analyte
are the predominant contributors to its
interactions with the electric field in
the ion source and thus represent the
primary determinants of the ionization
efficiency of each analyte. Accordingly,
among molecular classes comprised of
similarly charged or zwitterionic lipids,
the ionization efficiencies of individual
molecular species of lipids are largely
independent of the aliphatic chain length
within each lipid class analyzed in the
low-concentration regime. In caseswhere
analytes of interest do not carry an
inherent charge, ESI can be affected
through adduction with other anions or
cations in solution to induce charge
separation to facilitate ionization. The
use of ESI and mass spectrometric anal-
ysis of molecular ions directly from lipid
extracts led to many new insights intoª2011 Elsevier Ltd All rights reservedthe complexity of lipids in mammalian
cell membranes (Han and Gross, 1994),
the roles of phospholipase-mediated
cleavage of arachidonoyl containing lipids
in modulating the gating currents of
voltage-dependent ion channels (Gubi-
tosi-Klug et al., 1995), the presence of
chain elongation of acylcarnitine molec-
ular species during myocardial ischemia
(Ford et al., 1996), the identification of
a-oxidation in adipocytes (Su et al.,
2004), and dynamic alterations in cardio-
lipin content and molecular species
distribution that occur during diabetes
and obesity that lead to mitochondrial
dysfunction (Han et al., 2007).
The dramatic increase in sensitivity
resulting from ESI for mass spectrometric
analysis of lipids clearly represented an
enabling event in the growth and
development in the field of lipidomics.
Moreover, the robust increase in signal
to noise during ESI readily led to applica-
tion of tandem mass spectrometric
approaches for lipid analysis (Han and
Gross, 1995) allowing discrimination of
the multiple isobaric and isomeric molec-
ular species present at each m/z value.
The assignment of the aliphatic chain
composition and the regiospecificity of
aliphatic chains could be directly deter-
mined by ESI MS/MS through the differ-
ential fragmentation kinetics of aliphatic
moieties present at the sn-1 and sn-2
positions (Han and Gross, 1996). Two
basic approaches for ESI MS/MS have
been developed, each with context
dependent strengths and limitations.
In the traditional approach, lipids are
separated by HPLC and directly sprayed
into the ESI ion source for mass spectro-
metric analysis by molecular ion moni-
toring in conjunction with product ion
analysis, selected reaction monitoring
(SRM), or other fragmentation strategies.
In a second approach, termed Shotgun
Lipidomics, direct infusion of organic
extracts of tissues, cells, and biologic
fluids into the mass spectrometer is per-
formed. Direct infusion of organic
extracts allows marked increases in the
signal to noise ratio of molecular ions
corresponding to individual molecular
species. Concurrently, direct infusion
facilitates the utilization of a wide variety
of informative fragmentation strategies
that are not limited by the transient elution
of individual lipid molecular species
during column chromatography.
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Figure 2. Electrospray Ionization Mass Spectrometric Analysis of
Extracts of Murine White Adipose Tissue by MDMS-SL
Bligh and Dyer extracts of white adipose tissue from mice fed a high-fat diet
were prepared as previously described (Han and Gross, 2005) and directly
infused into the ESI ion source. Positive-ion ESI mass spectra identified
multiple molecular ions in the full mass scan (top row; x axis) that were quan-
titated through ratiometric comparisons with internal standard (tri 17:1 triacyl-
glycerol, m/z 849.8) after corrections for isotope abundance and acyl chain
length and unsaturation effects. Tandem mass spectrometric analysis was
performed using neutral loss scanning for the indicated naturally occurring
aliphatic chains. All scans were normalized to the base peak of the individual
spectrum. Through bioinformatic analysis of the ion counts in each row (x axis
scan) and column (y axis scans), the compositional identities of each individual
molecular species can be determined and their relative abundance can be
quantified.
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Spectrometry-Based
Shotgun Lipidomics
The large majority of cellular
lipids are comprised of linear
combinations of aliphatic
chains and polar head groups
that are covalently linked to a
glycerol or sphingosine back-
bone. Accordingly, determi-
nation of the head group
structure as well as the nature
and regiospecificity of the
aliphatic chains represents a
formal structural identification
of the overwhelming majority
of lipids. To exploit the limited
degrees of freedom in lipid
structure, in conjunction with
chemically predictable frag-
mentation patterns during
tandem mass spectrometry,
we developed multidimen-
sional mass spectrometry-
based Shotgun Lipidomics
(MDMS-SL) (Han and Gross,
2005) that has served as a
critical technology to under-
stand the multiple roles of
lipids in biologic function.
MDMS-SL is comprised of
four component parts
including: (1) multiplexed
extractions and chemistries;
(2) intrasource separation of
lipids based upon their
intrinsic electrical propensi-
ties; (3) multidimensional
mass spectrometry; and (4)
bioinformatic array analysis.
MDMS-SL begins with a mul-
tiplexed series of extractions
and chemistries that are opti-
mized to collectively result in
the integrated analysis of
over 30 lipid classes leading
to the identification and quan-
titation of many hundreds to
thousands of lipid molecular
species directly from lipidextracts. Through alterations in the pH of
the infusate solution, the highly selective
ionization of groups of specific lipid
classes based on their intrinsic electrical
properties could be effectively achieved
within the ion source (Han et al., 2004).
This process, now known as intrasource
separation, results in the resolution of lipid
constituents in the ion source, therebyeffectively replacing the need for chroma-
tography prior to mass spectrometric
analysis. Through construction of multidi-
mensional arrays of full mass scans of
molecular ions with precursor ion scan-
ning or neutral loss scanning of aliphatic
chains, polar head groups, and other
informative product ions, a comprehen-
sive description of the diversity of lipidChemistry & Biology 18, March 25, 2011 ª2011 Elsestructures within biologic
samples can be defined di-
rectly from their organic ex-
tracts. For example, if neutral
loss scanning of aliphatic
chains present in triglycerides
for all major biologically
occurring aliphatic chains is
performed, then extending
a perpendicular line from any
m/z value of the full mass
scan identifies the nature
and relative abundance of
fragment ions at each cross
peak (Han and Gross, 2001)
(Figure 2). Bioinformatic array
analysis of these cross peaks
can then be used to identify
the structure of each indi-
vidual isobaric lipid molecular
species present at each m/z
value in the full mass scan.
In this two dimensional array,
the first dimension comprises
the molecular ions (shown
on the x axis), while the
second dimension corre-
sponds to the mass of indi-
vidual aliphatic chains that
are subject to neutral loss
scanning. These two-dimen-
sional mass spectrometric
arrays have units of mass in
each dimension and thus are
analogous in both concept
and principle to 2D-NMR
plots which derive structural
information from through-
space or through-bond
connectivities present in the
targeted molecule, but have
units of frequency on each
axis. Thus, these two-dimen-
sional maps of lipid structure
have been referred to as
two-dimensional mass spec-
trometry (2D-MS) since they
are entirely analogous to 2D-
NMR spectroscopy. More-
over, additional dimensionscan be accessed through precursor ion
or neutral loss scanning of multiple sets
of informative fragment ions under differ-
ential conditions (e.g., polar head groups,
varied collision energies) thereby
providing a high-density matrix of struc-
tural information in n-dimensional space.
These multidimensional spectra are
ideally suited to bioinformatic arrayvier Ltd All rights reserved 287
Figure 3. Enhanced Shotgun Lipidomics Approaches
The analytic power of shotgun lipidomics can be extended through exploiting the unique chemical char-
acteristics of specific lipid classes. These include the derivatization of lipid moieties to increase signal
intensity and/or engender a mass shift to facilitate mass spectrometric analyses, the use of a M+1/2 iso-
topologue approach for doubly negatively charged cardiolipins, multiplexed extractions including liquid/
liquid partitioning, liquid/solid partitioning (solid phase extraction), and/or alkaline hydrolysis to enrich for
sphingolipids or ether lipids. In some tissues (e.g., adipose tissue), the removal of nonpolar lipids by
hexane extraction is judicious prior to the subsequent analysis of polar lipid constituents.
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tification and quantitation of many
hundreds to thousands of lipid molecular
species. This strategy is also well suited
for quantitation of individual molecular
species through utilization of ratiometric
comparisons using a two-step approach.
This two-step procedure optimally uses
the advantages of both exogenously
added internal standards as well as
endogenous lipid constituents as stan-
dards for tandem mass spectrometry by
using endogenous molecular species
whose mass content is known with high
precision through their intensities in the
full mass scan. Through this tandem
mass spectrometric approach, the
dynamic range of quantitation is extended
by over two orders of magnitude and is
accomplished with greater precision
through exploiting multiple additional
comparisons using endogenous molec-
ular speciesas standards.Finally,wepoint
out the utility of alterations in the ionization
conditions, ramping of collision energies,
examination of fragmentation kinetics
andn-dimensional scanningof informative
fragment ions that each provide additional
dimensions to substantiate structural
identification andquantitation of the abun-
danceof identified lipidmolecular species.
Advantages and Limitations
of Multidimensional Mass
Spectrometry-Based Shotgun
Lipidomics
The obvious advantage of MDMS-SL is
the direct acquisition of high-density infor-
mation on lipid structure and abundance
directly from biological extracts using the
mass spectrometer as a separations288 Chemistry & Biology 18, March 25, 2011device thereby avoiding the need for chro-
matography. A second advantage of
MDMS-SL is through direct infusion
large increases in S/N can be achieved
in comparison to chromatographic ap-
proaches where limited amounts of time
for signal acquisition and tandem mass
spectrometric analyses are available. A
third benefit of MDMS-SL is that it does
not require previous knowledge of the
compound(s) present in the mixture to
identify transitions, but rather interrogates
all mass space that contains naturally
occurring aliphatic chains, head groups,
and signature fragmentation ions through
precursor ion and neutral loss scanning,
thereby allowing for the identification of
previously unknown compounds. A fourth
use of MDMS-SL is the benefit from anal-
ysis of peak contours in multidimensional
space that lead to multiple bioinformatic
advantages that facilitate refinements in
quantitation through corrections for peak
shape, mass offset, and isotopologue
analysis. A fifth advantage of MDMS-SL
is that it is ideally suited to exploit the
distinctive chemical characteristics of
many lipid classes. Prominent examples
include the use of theM+1/2 isotopologue
approach for cardiolipin analyses (Han
et al., 2006), theuseof Fmocderivatization
for the analysis of ethanolamine contain-
ing constituents (Glaser and Gross,
1995), the use of specifically deuterated
amine selective reagents for ratiometric
quantitation through precursor ion scan-
ning (Zemski Berry et al., 2009), alkaline
hydrolysis to greatly enhance penetrance
into the sphingolipidome (Jiang et al.,
2007) and charge-switch derivatization
methods to greatly increase the sensitivityª2011 Elsevier Ltd All rights reservedfor eicosanoid analyses (e.g., Bollinger
et al., 2010) (Figure 3).
One limitation of MDMS-based SL is
the limits of detection and quantitation
that are feasible for low abundance
species. Currently, the lower limits of
detection for lipids in favorable cases
using MDMS-SL are in the high attomole
to low femtomole level. Although the
MDMS-SL approach takes advantage
of the 4 orders of magnitude dynamic
range inherent in mass spectrometry, we
explicitly point out that enrichment ap-
proaches are necessary for examination
of extremely low abundance lipids which
shotgun lipidomics is unable to access
with the sensitivities of currently available
mass spectrometers. Chromatographic
separation, liquid-liquid partitioning, solid
phase extraction, and other enrichment
methods can greatly extend the limits of
detection for extremely low abundance
molecular species. In our hands, chro-
matographic enrichment ofmany different
classes of low abundance lipids is most
effectively accomplished by orthogonal
chromatographies employing an initial
straight phase (or SCX) separation that re-
solves lipid classes followed by RPHPLC
to affect the resolution of lipid subclasses
and individual molecular species within
each class. Even with orthogonal chroma-
tographies, multiple molecular species
are typically present at each m/z value
that require analysis by tandem mass
spectrometric approaches. A second
limitation of MDMS-SL is the difficulty in
the localization and the stereochemistry
of the olefinic linkages in aliphatic chains
which can be accessed through multi-
stage fragmentation. A third limitation of
MDMS-SL is the inability to discriminate
enantiomeric lipids. Through chiral chro-
matography, Blair et al. resolved eicosa-
noid enantiomers for direct mass spectro-
metric analysis (Lee and Blair, 2009).
Whether direct infusion, chromatographic
enrichment, partitioning, or derivatization
is used, many of the strategic advantages
of multidimensional mass spectrometry
can be readily accessed.
The Future Challenges
of Lipidomics
The future challenges of lipidomics in-
clude the development of chemistries and
technologies to increase the penetrance
into the lipidome, identification of the
subcellular compartments or domains
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cellular adaptation or disease, and the
development of bioinformatic approaches
to define changes in lipid metabolic
networks that can predict the onset of
disease, identify disease progression,
and evaluate treatment efficacy. The
development of increasingly sophisti-
cated databases that contain the exact
mass, fragmentation patterns, and HPLC
elution characteristics of each lipid
molecular species is essential for the
continued development of lipidomics and
in its application to biomedical research.
Currently, there are three main databases
that are routinely utilized for lipidomics
research including METLIN (Smith et al.,
2005), The HumanMetabolome Database
(Wishart et al., 2008), and LIPID MAPS
(Sud et al., 2007). Through the use of ESI
in conjunction with time of flight mass
spectrometry, Shevchenko et al. used
a shotgun lipidomics strategy in conjunc-
tion with custom software to identify
over 250 lipids from yeast (Ejsing et al.,
2009). Dennis et al. identified over 400
lipids in RAW 267.2 cells using the
LIPID MAPS database and demonstrated
alterations in multiple lipid classes and
molecular species after cellular stimula-
tion (Dennis et al., 2010). Siuzdak et al.
identified over 150 lipids in stem cells
during differentiation and found increases
in the unsaturation index of aliphatic
chains that alter membrane structure
and dynamics during differentiation
(Yanes et al., 2010). Collectively, these
studies demonstrate the dynamic role of
alterations in lipid molecular species
content and membrane composition
that serve to facilitate cellular differentia-
tion and cellular activation. Through
orchestrating changes in membrane lipid
composition, molecular structure, and
membrane dynamics the execution of
intrinsic biologic programs (e.g., differenti-
ation) or responses to external perturba-
tions necessary for life processes are
facilitated.
Many other methods for ionization of
lipids for mass spectrometry have been
used with great success. In pioneering
work, Marshall et al. demonstrated the
utility of matrix assisted laser desorption/
ionization (MALDI) for lipid analysis in
conjunction with high mass accuracy
using FT-ICR (Marto et al., 1995). The
use of laser-based methods have the
obvious advantage of allowing highthroughput analyses with rapid repetition
rate lasers that are unencumbered by
the time constraints normally encoun-
tered using fluid-based methods for
mass spectrometry. The use of MALDI/
TOF-TOF mass spectrometry for lipido-
mic analysis of biologic tissues has
recently been further developed for
high throughput lipidomics where many
dozens of samples can be directly
analyzed within minutes facilitating the
large scale application of lipidomics
to human disease through this high
throughput approach (Sun et al., 2008).
Moreover, laser or beam ionization
methods provide a platform for innovative
chemical strategies for matrix construc-
tion that can be exploited for selective
ionization (e.g., the selective ionization/
desorption of discrete lipid classes) or
can be used for nonbiased identification
and quantitation of analytes. In elegant
work, Siuzdak et al. engineered nano-
structured surfaces to trap fluorinated
siloxanes that desorb analytes upon
laser-induced vaporization (e.g., Northen
et al., 2007). Through multiplexing differ-
ent surface-based technologies, doping
with selected cavitands, and the con-
struction of engineered charge transfer
complexes to facilitate class-specific ioni-
zation, the future growth of MALDI TOF/
TOF mass spectrometry is assured.
Moreover, recent success with MALDI
imaging (Reyzer and Caprioli, 2005),
desorption ESI (DESI) imaging (Takats
et al., 2004) techniques, and nanostruc-
tured surfaces (Patti et al., 2010) has led
to new insights into the spatial distribution
of lipids in tissues, but at present these
methods are limited by constraints on
spatial resolution. A prominent issue in
lipidomics is the identification of methods
to delineate alterations in membrane
composition in discrete subcellular loci
or within specific membrane domains.
Thus, the development of methods which
precisely localize changes in specific
compartments or domains in intact cells
is a fundamental goal of future lipidomics
research. The use of secondary ion mass
spectrometry using ion beams has greatly
enhanced spatial resolution to the order
of 100 nm that can identify lipids in
specific membrane domains (Winograd
and Garrison, 2010). Additional techno-
logic advances are anticipated in these
fields that will define spatially privileged
domains within cell membranes andChemistry & Biology 18, March 25, 2011subcellular compartments, identify un-
known lipids and greatly facilitate our
understanding of membrane structure
and function.
Nuclear magnetic resonance (NMR)
spectroscopy has been used to identify
a wide variety of lipids in biological
systems (e.g., Lindon and Nicholson,
2008 and references therein). Mountford
and colleagues used 1H NMR to distin-
guish invasive breast cancer from benign
lesions on the basis of increased total
choline phospholipid species (MacKinnon
et al., 1997). While NMR is a nondestruc-
tive and nonselective technique that
provides unique information pertaining to
molecular structure and dynamics, its
modest sensitivity and resolving power
to distinguish individual chemical species
in comparison to mass spectrometry has
limited utilization of NMR in lipidomics
investigations. NMR interpretation is also
complicated by the considerable number
of spin-coupled multiplets that result in
spectral crowding. Recently this problem
has been addressed by using two-dimen-
sional J-resolved NMR spectroscopy
to visualize metabolite chemical shifts
and J-couplings along different spectral
dimensions and thereby increase peak
dispersion (Ludwig and Viant, 2010). An
advantage of magnetic resonance
approaches is the ability to analyze lipids
noninvasively in intact cells and tissues
without losing chemical information about
the analyte environment (Beckonert et al.,
2010). A review of the methods used
in high-resolution magic-angle spinning
NMR, their application to lipidomics and
their potential biomedical uses have
been discussed recently (Fonville et al.,
2010). Moreover, selective recoupling of
dipolar and chemical-shift interactions
removed by magic-angle spinning in the
solid state allows for the characterization
of regulatory interactions, dynamics, and
ion channels within biological membranes
(Guillion and Schaefer, 1989; deAzevedo
et al., 1999; Kim et al., 2009; Cady et al.,
2010). Since NMR is a nondestructive
technique, it can be used to interrogate
alterations in lipid structure and dynamics
in biochemically functioning cells. Thus, it
is anticipated that future developments
will provide critical information on alter-
ations in membrane structure and func-
tion through the synergistic application
of a variety of solution state and solid-
state NMR approaches.ª2011 Elsevier Ltd All rights reserved 289
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The past decades have witnessed the
rapid growth and development of lipido-
mics, which has now become an essential
part of Systems Biology. Multidimen-
sional mass spectrometry-based shotgun
lipidomics has now been developed into
a robust technology that can be used
to provide rapid access to the mecha-
nisms underlying diverse disease states.
Continuing advances in ionization tech-
nologies, use of high mass accuracy
lipidomics, novel fragmentation strate-
gies, improvements in enrichment ap-
proaches, and enhanced spatial resolu-
tion in conjunction with NMR-based
approaches will collectively lead to the
development of a comprehensive under-
standing of the pleiotropic roles of lipids
in cellular function.
Chemistry & Biology invites your
comments on this topic. Please write
to the editors at chembiol@cell.com.
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